Determining the Sustained Virologic Response of Declatasvir in Egyptian Patients With Hepatitis C Virus Genotype 4

Exclusion Criteria

• •Total serum bilirubin \> 3 mg/dl.
• •Serum albumin \< 2.8 g/dl.
• •INR ≥ 1.7
• •Platelet count \< 50000/mm3.
• •Hepatic cell carcinoma except four weeks after intervention aiming to cure with no evidence of activity by dynamic imaging (CT or MRI).
• •Extra hepatic malignancy except after two years of disease free interval
• •Pregnancy or inability to use contraception.
• •Inadequately controlled diabetes mellitus (HbA1c \> 9%).